Release Date: 31/03/11 14:22 Summary: Half Yearly Report and Accounts December 2008 Price Sensitive: No Download Document 658.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%